Nyxoah is a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA). (Image courtesy of Nyxoah webpage)
REGULATED INFORMATION
Information on the total number of voting rights and shares
Mont-Saint-Guibert, Belgium, Nov. 27 (Korea Bizwire) – In accordance with article 15 of the Law of 2 May 2007 on the disclosure of large shareholdings, Nyxoah SA (Euronext Brussels and Nasdaq: NYXH) publishes the below information following the issue of new shares.
- Share capital: EUR 6,429,682.56
- Total number of securities carrying voting rights: 37,427,265 (all ordinary shares)
- Total number of voting rights (= denominator): 37,427,265 (all relating to ordinary shares)
- Number of rights to subscribe to securities carrying voting rights not yet issued: 2,296,194 (all granted subscription rights; this number excludes 346,431 subscription rights that were issued but not yet granted)
*
* *
Contact:
Nyxoah
John Landry, CFO
IR@nyxoah.com
Attachment
Source: Nyxoah via GLOBE NEWSWIRE
